Skip to content

Study on risk factors and efficacy prediction model of residual symptoms in patients with anxiety or depression disorders after treatment

Study on risk factors and efficacy prediction model of residual symptoms in patients with anxiety or depression disorders after treatment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057365
Enrollment
Unknown
Registered
2022-03-09
Start date
2022-03-07
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual symptoms of anxiety or depression disorders

Interventions

Case series:None

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with anxiety and depression: 1. 18-60 years old; 2. Meet the diagnostic criteria of DSM-V depression or anxiety disorder, HAMD = 14 points or HAMA = 14 points; 3. No contraindication of MRI, EEG and other examinations; 4. Right handedness; 5. The education level is primary school graduate or above, the mother tongue is Chinese, and the informed consent form is signed. Inclusion criteria for healthy controls: 1. 18-60 years old; 2. Healthy subjects; 3. No contraindication of MRI, EEG and other examinations; 4. Right handedness; 5. The education level is primary school graduate or above, the mother tongue is Chinese, and the informed consent form is signed.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with anxiety and depression: 1. Mental disorders include schizophrenia, severe depression with suicidal tendency, alcoholism or other substance abuse; 2. Complicated with other system diseases that seriously affect the prognosis; 3. Patients with contraindications to antidepressants; 4. Aphasia, deafness, blindness, etc. cannot cooperate with the assessment or are combined with cognitive dysfunction; 5. Lactation period, pregnancy or pregnancy plan during the trial period; 6. Closed phobia, metal products in the body, etc. are not suitable for MRI examination; 7. Anxiety or depression caused by intracranial organic diseases. Exclusion criteria for healthy controls: 1. Emotional disorders include anxiety disorder, depression disorder, bipolar disorder, etc; 2. Mental disorders include schizophrenia, severe depression with suicidal tendency, alcoholism or other substance abuse; 3. Complicated with other system diseases that seriously affect the prognosis; 4. Aphasia, deafness, blindness, etc. cannot cooperate with the assessment or are combined with cognitive dysfunction; 5. Lactation period, pregnancy or pregnancy plan during the trial period; 6. Closed phobia, metal products in the body, etc. are not suitable for MRI examination; 7. Anxiety or depression caused by intracranial organic diseases.

Design outcomes

Primary

MeasureTime frame
Residual symptoms;

Countries

China

Contacts

Public ContactYuan Yang

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

yuanyang70@hotmail.com+86 13995561816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026